+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neodymium-YAG laser vitreolysis in sickle cell retinopathy



Neodymium-YAG laser vitreolysis in sickle cell retinopathy



Archives of Ophthalmology 105(8): 1087-1091



Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040780096

Download citation: RISBibTeXText

PMID: 3632418

DOI: 10.1001/archopht.1987.01060080089034


Related references

Vitreolysis of vitreous band in a case of proliferative diabetic retinopathy using q switched neodymium yag laser. Rinsho Ganka 42(6): 721-724, 1988

Neodymium:YAG laser vitreolysis. International Ophthalmology Clinics 25(3): 125-134, 1985

Triamcinolone-assisted neodymium:YAG laser vitreolysis. Ophthalmic Surgery Lasers and Imaging 39(3): 234-236, 2008

Neodymium yag laser vitreolysis for treatment and prophylaxis of cystoid macular edema. Australian & New Zealand Journal of Ophthalmology 17(2): 179-183, 1989

Q-switched neodymium YAG laser vitreolysis in the therapy of posterior segment disease. Graefe's Archive for Clinical and Experimental Ophthalmology 228(3): 222-225, 1990

Neodymium:YAG laser anterior vitreolysis for Irvine-Gass cystoid macular edema. Journal of Cataract and Refractive Surgery 15(3): 304-307, 1989

Results of YAG-laser vitreolysis in proliferative diabetic retinopathy complicated by vitreous hemorrhage. Vestnik Oftalmologii 130(4): 22-26, 2014

Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease. Medicine 90(6): 372-378, 2011

Laser therapy for retinopathy in sickle cell disease. Cochrane Database of Systematic Reviews 2015(10): Cd010790, 2015

Transscleral and transpupillary laser coagulation in proliferative sickle-cell retinopathy. Der Ophthalmologe 98(2): 199-202, 2001

Trans-scleral diode laser photocoagulation in proliferative sickle cell retinopathy. Ophthalmology 106(9): 1828-1829, 1999

Neodymium-YAG laser and diabetic retinopathy. Archives of Ophthalmology 110(5): 619, 1992

Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. American Journal of Ophthalmology 152(4): 704-711.E2, 2011

Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia. Clinical Hemorheology and Microcirculation 55(2): 205-212, 2013